Stable chlorine dioxide sustained-release gel preparation and preparation method and application thereof
A chlorine dioxide gel and chlorine dioxide technology, applied in the new application of preparations for rapid hemostasis, in the field of preparation preparation, can solve problems such as application research limitations
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0018] ①Based on 100 parts by weight, weigh 10 parts of carboxymethylcellulose sodium, and evenly disperse it in 90 parts of 18-25mg / ml stable chlorine dioxide solution. Stir evenly to obtain the stable chlorine dioxide gel A system;
[0019] ②Based on 100 parts by weight, take 20 parts of Carbomer 940, and evenly disperse it in 70 parts of acetic acid solution with a pH of 2.6-3.5. After fully swelling, add 10 parts of glycerin under stirring condition of 400-650r / min, Mix evenly to get the activated gel B system;
[0020] ③Before use, mix system A and system B uniformly at a ratio of 1:0.8 to form a stable chlorine dioxide slow-release gel.
[0021] This product uses a drug transdermal absorption device for in vitro release simulation test. Dialysis membrane radius D=21mm, molecular weight cut-off is 12000-14000Da. Under the condition of temperature of 37±0.5°C, take the liquid at 1, 2, 4, 6, 8, 10, 11, 12, and 24 hours for measurement, according to "Pharmacopoeia of the ...
Embodiment 2
[0024] ①Based on 100 parts by weight, weigh 20 parts of sodium carboxymethylcellulose and 5 parts of sodium alginate, and evenly disperse them in 75 parts of stable chlorine dioxide solution of 18-25mg / ml. Under the condition of -650r / min, stir evenly to obtain the stable chlorine dioxide gel A system;
[0025] ②Based on 100 parts by weight, take 15 parts of Carbomer 940 and evenly disperse them into 77 parts of acetic acid solution with a pH of 2.6-3.5. After fully swelling, add 8 parts of glycerin under the stirring condition of 400-650r / min, Mix evenly to get the activated gel B system;
[0026] ③Before use, mix system A and system B uniformly at a ratio of 1:1.5 to form a stable chlorine dioxide slow-release gel.
[0027] This product uses a drug transdermal absorption device for in vitro release simulation tests. Dialysis membrane radius D=21mm, molecular weight cut-off is 12000-14000Da. Under the condition of temperature of 37±0.5°C, take the liquid at 1, 2, 4, 6, 8, ...
Embodiment 3
[0030]①Based on 100 parts by weight, weigh 20 parts of sodium carboxymethylcellulose and 10 parts of sodium alginate, and evenly disperse them in 70 parts of 18-25mg / ml stable chlorine dioxide solution. Under the condition of -650r / min, stir evenly to obtain the stable chlorine dioxide gel A system;
[0031] ②Based on 100 parts by weight, take 20 parts of Carbomer 940, and evenly disperse it in 70 parts of acetic acid solution with a pH of 2.6-3.5. After fully swelling, add 10 parts of glycerin under stirring condition of 400-650r / min, Mix evenly to get the activated gel B system;
[0032] ③Before use, mix system A and system B uniformly at a ratio of 1:1 to form a stable chlorine dioxide slow-release gel.
[0033] This product uses a drug transdermal absorption device for in vitro release simulation tests. Dialysis membrane radius D=21mm, molecular weight cut-off is 12000-14000Da. Under the condition of temperature of 37±0.5°C, take the liquid at 1, 2, 4, 6, 8, 10, 11, 12,...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 